INFLAMMATORY MYOSITIS

Clinical trials for INFLAMMATORY MYOSITIS explained in plain language.

Never miss a new study

Get alerted when new INFLAMMATORY MYOSITIS trials appear

Sign up with your email to follow new studies for INFLAMMATORY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New 'Off-the-Shelf' cell therapy trial targets six severe autoimmune diseases

Disease control Not yet recruiting

This early-stage study is testing a new cell therapy called BCT301 for people with severe autoimmune diseases that haven't responded to standard treatments. The therapy uses lab-made immune cells designed to target and remove harmful B cells, which are thought to drive these dise…

Matched conditions: INFLAMMATORY MYOSITIS

Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

INFLAMMATORY MYOSITIS

Get alerted when new INFLAMMATORY MYOSITIS trials appear

New 'Off-the-Shelf' cell therapy trial targets six severe autoimmune diseases